All filters
Videos
Current reality: The San Francisco experience | Meredith Greene, MD
Presented at:
International Workshop on HIV & Aging 2017
Videos
Exercise and aging | Wendy Kohrt, PhD
Presented at:
International Workshop on HIV & Aging 2017
Videos
OMICS in the context of aging and Alzheimer's disease | Madhav Thambisetty, MD
Presented at:
International Workshop on HIV & Aging 2017
Videos
The biology of superagers | Nir Barzilai, MD
Presented at:
International Workshop on HIV & Aging 2017
Videos
Clinical Trials Targeting Aging to Extend Healthy Lifespan | Jamie Justice, PhD
Presented at:
International Workshop on HIV & Aging 2017
Videos
Optimizing Clinical Utility of Integrase Inhibitors | Anton Pozniak, MD, FRCP
Presented at:
Global HIV Clinical Forum 2017
Videos
Clinical Case -Reduced Drug Regimen | Pedro Cahn, MD, PhD
Presented at:
Global HIV Clinical Forum 2017
Videos
The Role of Integrase Inhibitors during HIV prevention | Pep Coll, MD
Presented at:
Global HIV Clinical Forum 2017
Videos
Clinical Pharmacology related considerations | David Back, PhD
Presented at:
Global HIV Clinical Forum 2017
Videos
What challenges remain in viral hepatitis | Jürgen Rockstroh, MD
Presented at:
International Workshop on HIV & Hepatitis Co-infection 2017
Videos
HCV elimination program in Georgia: Successes and challenges | Nikoloz Chkhartishvili, MD, MS, PhD
Presented at:
International Workshop on HIV & Hepatitis Co-infection 2017
Videos
Antifibrotics and fatty liver drugs in the pipeline | Sanjay Bhagani, MD
Presented at:
International Workshop on HIV & Hepatitis Co-infection 2017
Videos
NASH and NAFLD in HIV: same or different? | Mariana Machado, MD
Presented at:
International Workshop on HIV & Hepatitis Co-infection 2017
Videos
Non liver and survival benefits of SVR in HCV | Marion Peters, MD
Presented at:
International Workshop on HIV & Hepatitis Co-infection 2017
Videos
The use of HIV+ or HCV+ organs in transplantation | Stefano Fagiuoli, MD
Presented at:
International Workshop on HIV & Hepatitis Co-infection 2017
Videos
Are there any special populations in treatment of HCV left? | Douglas Dieterich, MD
Presented at:
International Workshop on HIV & Hepatitis Co-infection 2017
Videos
Pharmacologist's perspective | David Back, PhD
Presented at:
International Workshop on HIV & Hepatitis Co-infection 2017
Videos
Virologist's perspective | Charles Boucher, MD, PhD
Presented at:
International Workshop on HIV & Hepatitis Co-infection 2017
Videos
Special considerations before / during / after DAA therapy | Kosh Agarwal, MD
Presented at:
International Workshop on HIV & Hepatitis Co-infection 2017
Videos
HBV cure: what is coming in 5 – 10 years? | Patrick Kennedy, MD
Presented at:
International Workshop on HIV & Hepatitis Co-infection 2017
Videos
EASL highlights 2017 | Jürgen Rockstroh, MD
Presented at:
International Workshop on HIV & Hepatitis Co-infection 2017